TRACON PHARMACEUTICALS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TCON and buy or sell other stocks, ETFs, and their options commission-free!About TCON
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2004
Founded2004
Employees—
Employees—
TCON Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume9.02K
Average volume9.02K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.75
52 Week high$14.75
52 Week low$0.002
52 Week low$0.002
Stock Snapshot
The current TRACON PHARMACEUTICALS(TCON) stock price is $0.03.
On 2026-01-02, TRACON PHARMACEUTICALS(TCON) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for TRACON PHARMACEUTICALS(TCON) stock has reached 0, versus its average volume of 9.02K.
Over the past 52 weeks, TRACON PHARMACEUTICALS(TCON) stock has traded between a high of $14.75 and a low of $0.00.
Over the past 52 weeks, TRACON PHARMACEUTICALS(TCON) stock has traded between a high of $14.75 and a low of $0.00.